Nearly forty pieces of social media (and assorted resources) on positive pregnancy, which you can post to Facebook or Twitter using our simple inbuilt social media scheduling tool. Not only does it engage your social network viewers, but each piece of social media links to a email lead collection form where people can sign up to receive the downloadable resources, meaning it also helps you to build your email list while adding value to your viewers.
Once they have entered their details, we collect those email details for you, and deliver them to the resources they have signed up to receive. This campaign also includes a range of 'lead magnets' (high value pieces of content) which your viewers can download once they've entered their email address (don't worry, we take care of the whole process for you). You can use the campaign to grow your email list, create engaging and informative social media pages and build your reputation and authority by publishing some super-helpful content to your social networks.
You can download a couple of patients leaflet and three free social media images by logging in (or registering) for a free account below.
Register today to access free content
Thank you. Your account has been created and you have now been logged in. We will send you an email so that you can set your password for future use.
Unfortunately your current subscription does not include access to the new Co-Kinetic Business Growth and Marketing section. This is either because you have an old legacy Full Site subscription which requires an upgrade or you have another subscription which doesn't include access to the Business Growth element of the site.
This new part of the Co-Kinetic platform is designed to:
To access this new section, we need you to upgrade to add the Business Growth subscription to your account. (more details here).
Don't worry, it's RISK FREE. If you don't wish your subscription to continue after this time, simply
cancel your Business Growth subscription before the trial expires and your original content
subscription will continue as before.